Michel Mikhail - 15 Nov 2021 Form 4 Insider Report for NAVIDEA BIOPHARMACEUTICALS, INC.

Role
Chief Regulatory Officer
Signature
/s/ Erika L. Eves for Michel Mikhail, by power of attorney
Issuer symbol
N/A
Transactions as of
15 Nov 2021
Net transactions value
+$75
Form type
4
Filing time
02 Dec 2021, 15:08:57 UTC
Previous filing
05 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NAVB Stock Option Award $75 +75,000 $0.001000* 75,000 15 Nov 2021 Common Stock 75,000 $1.37 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options granted pursuant to Issuer's 2014 Amended and Restated Stock Incentive Plan, which vest as to one-third on each of the first three anniversaries of the date of grant.